Skip to main content
EducationHarm Reduction

LGBTQ+ History and Harm Reduction

By May 30, 2025No Comments

Looking for LGBTQ+-friendly resources?

Click here.

LGBTQ+ Community and Harm Reduction:

The Roots of the HIV/AIDS Epidemic

By: Mia Dickinson & Lucy Connery

Introduction

Lesbian, Gay, Bisexual, Transgender, and Queer+ (LGBTQ+) community members are largely responsible for present-day harm reduction strategies. As pioneers of public health, this community led efforts to improve health outcomes related to Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS). These conditions were largely misunderstood in the 1980s and 90s; many believed that these diseases only impacted members of the LGBTQ+ community, or individuals who engaged in “risky” behaviors such as substance use or unprotected sex. These misunderstandings, which were rooted in bias and stigma, along with inaction from the United States government, led to a crisis that claimed nearly 450,000 lives by the year 2000 (Centers for Disease Control and Prevention [CDC], 2001; U.S. Health and Human Services, 2025).

Beginnings of the AIDS Epidemic

The first official reporting of the AIDS epidemic came from the Centers for Disease Control and Prevention (CDC) in 1981. The CDC published an article on pneumocystis carinii pneumonia (PCP), describing cases of the rare lung infection in five young, previously healthy gay-identified men in Los Angeles (U.S. Health & Human Services, n.d.). It was also reported that the men had other unusual infections, indicating that their immune systems were not functioning properly. 

The same day that the PCP article was published, New York dermatologist Dr. Alvin Friedman-Kien called the CDC to report a cluster of cases of a rare and unusually aggressive cancer, kaposi’s sarcoma (KS), among gay men in New York and California. Like PCP, KS is associated with people who have weakened immune systems. In response to these reports, the CDC established the Task Force on Kaposi’s Sarcoma and Opportunistic Infections to identify risk factors and to develop a definition of the disease so that they could begin national surveillance of new cases.

By the end of 1981, there was a cumulative total of 337 reported cases of individuals with severe immune deficiency in the United States: 321 adults/adolescents and 16 children under age 13. Of those cases, 130 died by December 31, 1981 (U.S. Health & Human Services). By 1984, more than 7,700 people contracted AIDS and about 3,500 people died from it. However, the U.S. government did not publicly mention the disease until September of 1985 (Bennington-Castro, 2025).

LGBTQ+ Community Leaders Emerge

Among the most visible early figures were Bobbi Campbell and Michael Callen, two gay men living with AIDS who fought stigma and demanded action (Wright, 2013). Bobbi Campbell, a nurse in San Francisco, was one of the first people to publicly come out as having AIDS. He wrote about his experiences in a newspaper column under the name “AIDS Poster Boy,” and posed for a now famous 1983 Newsweek cover with his partner. Campbell blended personal vulnerability with political courage, turning his diagnosis into a platform for education, visibility, and care.

Michael Callen, a musician and writer based in New York, was diagnosed in 1982 and then became a central figure in AIDS activism. He co-authored “How to Have Sex in an Epidemic”, one of the first community-based safer sex guides, and was a vocal advocate for the rights of people living with AIDS. Callen co-founded the People With AIDS Coalition and traveled widely to speak, educate, and organize, emphasizing that people living with AIDS should lead the response (Wright, 2013). Campbell and Callan both worked to challenge the idea that people with AIDS were helpless victims. They helped pioneer the “Nothing About Us Without Us” ethos that would become central to both AIDS advocacy and harm reduction work (Morrison, 2013; Rojas, 2024). Their advocacy helped to destigmatize AIDS and promote community-driven care in response to the U.S. Government’s lack of prompt action to control the growing epidemic.

The harm reduction movement was also deeply shaped by Black and queer liberation work, feminist organizing, and disability justice frameworks. These groups helped define what we now know as intersectionality – the idea that people are made up of multiple different identities that can result in both advantages and disadvantages. Black LGBTQ+ people also helped to inspire ideals of mutual aid, collective survival, and resistance to carceral responses to public health, which would continue to be integral to the harm reduction movement (Rojas, 2024). 

Roots of the Harm Reduction Movement

The silence around AIDS in the 1980s wasn’t just social, it was institutional (Vider, 2017; Shulman & Ciesemier, 2023). The federal government dragged its feet on funding, pharmaceutical companies prioritized profit over access, and mainstream media coverage was slow and stigmatizing. In this inaction, a new kind of activism emerged: protesting and civil disobedience.

In March 1987, playwright and activist Larry Kramer gave a speech at the Lesbian and Gay Community Services Center in New York City, urging the LGBTQ+ community to fight for their lives (Vider, 2017). The result was the formation of ACT UP (AIDS Coalition to Unleash Power), an advocacy group dedicated to confronting the AIDS crisis with urgency and rage. ACT UP’s first demonstration took place on March 24, 1987, on Wall Street, the heart of global finance. Protesters gathered outside the New York Stock Exchange to demand that pharmaceutical companies make experimental AIDS drugs available to those who needed them and to lower the price of existing treatments (Davis, 2017). This would be the first of several Wall Street actions in 1988, 1989, and 1997, each escalating in size and intensity (Davis, 2017).

ACT UP transformed the landscape of public health policy and pharmaceutical research (Schulman & Ciesemier, 2023; Vider, 2017; Wright, 2013). Through tactics like civil disobedience, media hijacking, and public education, ACT UP pressured government agencies, including the FDA and NIH, to accelerate drug approval processes and expand access to treatment. They also insisted that people living with HIV be included in clinical trials and decision-making processes. Their work helped catalyze the development and distribution of highly active antiretroviral therapy (HAART) in 1996, a treatment breakthrough that dramatically extended the lives of people living with HIV. What was once considered a death sentence became a manageable chronic illness for many, though access and equity are still ongoing struggles (Vider, 2017).

Modern Harm Reduction

Many modern harm reduction advocates cite the LGBTQ+ community as pioneers for harm reduction strategies. As HIV transmission grew among people who inject drugs (PWID), activists created underground needle exchange programs to prevent exposure, even though they were illegal at the time. Laws across the United States during the 1980s criminalized syringe services under drug paraphernalia laws, despite a growing body of evidence that limited access to sterile injection supplies only worsened the AIDS epidemic (Rhine, 2013). Most of these underground programs were led by people who use drugs, AIDS activists, and queer community organizers. As syringe service programs were not sanctioned public health projects, they were acts of civil disobedience.

Groups like ACT UP played a key role. Though best known for their confrontations with the FDA and pharmaceutical companies, ACT UP also had internal committees focused on syringe access, overdose prevention, and safer drug use education. These subgroups collaborated with emerging harm reduction organizations and fought for drug users to be included in broader AIDS activism (Rabkin et al., 2018).  They challenged the narrative that people suffering from addiction were undeserving of care, health, or autonomy.

By the late 1990s, national campaigns like the ACT NOW campaign (AIDS Coalition to Network, Organize, and Win) pushed for federal funding for syringe exchange programs, culminating in a series of high-profile demonstrations in Washington, D.C., in 1997–1998 (Pham, 2017). Participation in these demonstrations was criminalized by law enforcement agencies, but the arrests and ensuing press highlighted the community demand for access to sterile syringes and the consequences of denying that access. This period of community action laid the foundation for the harm reduction field as we know it today: syringe service programs, naloxone distribution, safer use education, and a growing push to decriminalize drug use are all outcomes of that initial underground work.

Conclusion

Individuals in the LGBTQ+ community have spearheaded the harm reduction movement since its roots in the HIV and AIDS epidemic in the 1980s and 90s. Through community organization and civil disobedience, groups like ACT UP and ACT NOW advocated for better health care and expanded access to services for traditionally marginalized communities. As a result of these community-based efforts, modern harm reduction initiatives like syringe services, naloxone distribution, and safe sex education have grown in number and scale. Due to the advocacy and resilience of the LGBTQ+ community, present-day treatment options for HIV and AIDS are better understood and more accessible than ever.  These efforts to combat HIV/AIDS and better serve people who use drugs have resulted in millions of lives saved around the globe.

References

Share